Hanife Bahsi

Statistics

Publications

Citations

690

H-Index

Active since

2015

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Prince of Wales Hospital

Johannes Gutenberg University Mainz

Lead Discovery Center (Germany)

Hanife Bahsi is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicinal chemistry, pharmacology, and molecular virology.

Publications per year

2015–2017

Publications

New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids

Christoph Reiter, Tony Fröhlich, Maen Zeino et al. · European Journal of Medicinal Chemistry · 2015 · 118 citations

Medicine, Medicinal Chemistry, Pharmacology +12

A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations

Corina Hutterer, Jan Eickhoff, Jens Milbradt et al. · Antimicrobial Agents and Chemotherapy · 2015 · 105 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components

Eric Sonntag, Stuart T. Hamilton, Hanife Bahsi et al. · Journal of General Virology · 2016 · 102 citations

Life Sciences, Cell Biology, Molecular Biology +12

Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions

Felix Held, Anton A. Guryev, Tony Fröhlich et al. · Nature Communications · 2017 · 93 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against <i>Plasmodium falciparum</i>, Human Cytomegalovirus, and Leukemia Cells

Tony Fröhlich, Christoph Reiter, Mohammad Ibrahim et al. · ACS Omega · 2017 · 82 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 9